N-glycomic profiling as a tool to separate rectal adenomas from carcinomas

Molecular and Cellular Proteomics

Volumn 14, Issue 2, 2015, Pages 277-288

  Kaprio, Tuomas ^a,b   Satomaa, Tero ^c   Heiskanen, Annamari ^c   Hokke, Cornelis H ^d   Deelder, André M ^d   Mustonen, Harri ^a   Hagström, Jaana ^e   Carpen, Olli ^f   Saarinen, Juhani ^c   Haglund, Caj ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c GLYKOS FINLAND LTD   (Finland)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF HELSINKI   (Finland)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE; SIALYL LEWIS X ANTIGEN; 5-ACETYLNEURAMINYL-2-3-GALACTOSYL-1-3-(FUCOPYRANOSYL-1-4)-N-ACETYLGLUCOSAMINE; ASPARAGINE; OLIGOSACCHARIDE; POLYSACCHARIDE;

ANTIGEN EXPRESSION; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CARBOHYDRATE ANALYSIS; ENZYME RELEASE; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; RECTUM ADENOMA; RECTUM CARCINOMA; ADENOMA; ADULT; AGED; CARCINOMA; COLORECTAL TUMOR; DISEASE COURSE; FEMALE; GLYCOBIOLOGY; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; RECTUM TUMOR; SURVIVAL; VERY ELDERLY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ASPARAGINE; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLYCOMICS; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGOSACCHARIDES; POLYSACCHARIDES; PRINCIPAL COMPONENT ANALYSIS; RECTAL NEOPLASMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL ANALYSIS;

EID: 84921911390     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.041632     Document Type: Article

References (32)

1. Lowe, J. B., and Marth, J. D. (2003) A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 72, 643-691
2. Marth, J. D., and Grewal, P. K. (2008) Mammalian glycosylation in immunity. Nat. Rev. Immunol. 8, 874-887
3. Hakomori, S. (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 52, 257-331
4. An, H. J., Kronewitter, S. R., de Leoz, M. L. A., and Lebrilla, C. B. (2009) Glycomics and disease markers. Curr. Opin. Chem. Biol. 13, 601-607
5. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., Ishikawa, O., Ito, T., Kato, M., Kasahara, A., Kawano, S., Gu, J., Taniguchi, N., and Miyoshi, E. (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 118, 2803-2808
6. Arnold, J. N., Saldova, R., Hamid, U. M. A., and Rudd, P. M. (2008) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8, 3284-3293
7. Ravindranath, M. H., Yesowitch, P., Sumobay, C., and Morton, D. L. (2007) Glycoimmunomics of human cancer: current concepts and future perspectives. Per. Med. 3, 201-214
8. Mungul, A. A., Cooper, L. L., Brockhausen, I. I., Ryder, K. K., Mandel, U. U., Clausen, H. H., Rughetti, A. A., Miles, D. W. D., Taylor-Papadimitriou, J. J., and Burchell, J. M. J. (2004) Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice. Int. J. Oncol. 25, 937-943
9. Kobata, A., and Amano, J. (2005) Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumors. Immunol. Cell Biol. 83, 429-439
10. Girnita, L. L., Wang, M. M., Xie, Y. Y., Nilsson, G. G., Dricu, A. A., Wejde, J. J., and Larsson, O. O. (2000) Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications. Anticancer Drugs 15, 67-72
11. Komatsu, M. M., Jepson, S. S., Arango, M. E. M., Carraway, C. A. C. C., and Carraway, K. L. K. (2001) Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor. Oncogene 20, 461-470
12. Yoshimura, M. M., Ihara, Y. Y., Matsuzawa, Y. Y., and Taniguchi, N. N. (1996) Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J. Biol. Chem. 271, 13811-13815
13. Granovsky, M., Fata, J., Pawling, J., Muller, W. J., Khokha, R., and Dennis, J. W. (2000) Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6, 306-312
14. Pili, R. R., Chang, J. J., Partis, R. A. R., Mueller, R. A. R., Chrest, F. J. F., and Passaniti, A. A. (1995) The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res. 55, 2920-2926
15. Arnold, J.N., Saldova, R., Calligan, M.C., Murphy, T.B., Mimura-Kimura, Y., Telford J.E., Godwin, A.K., Rudd, P.M. (2011) Novel glycan biomarkers for the detection of lung cancer. J. Proteome Res. 10, 1755-1764
16. Satomaa, T., Heiskanen, A., Leonardsson, I., Angstrom, J., Olonen, A., Blomqvist, M., Salovuori, N., Haglund, C., Teneberg, S., Natunen, J., Carpen, O., and Saarinen, J. (2009) Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res. 69, 5811-5819
17. Abd Hamid, U. M., Royle, L., Saldova, R., Radcliffe, C. M., Harvey, D. J., Storr, S. J., Pardo, M., Antrobus, R., Chapman, C. J., Zitzmann, N., Robertson, J. F., Dwek, R. A., and Rudd, P. M. (2008) A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18, 1105-1118
18. Balog, C. I. A., Stavenhagen, K., Fung, W. L. J., Koeleman, C. A., McDonnell, L. A., Verhoeven, A., Mesker, W. E., Tollenaar, R. A. E. M., Deelder, A. M., and Wuhrer, M. (2012) N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. Mol. Cell Proteomics 11, 571-585
19. Zhao, Y.-P. Y., Ruan, C.-P. C., Wang, H. H., Hu, Z.-Q. Z., Fang, M. M., Gu, X. X., Ji, J. J., Zhao, J.-Y. J., and Gao, C.-F. C. (2012) Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling. Cancer 118, 639-650
20. Siegel, R., Naishadham, D., and Jemal, A. (2012) Cancer statistics, 2012. CA. Cancer J. Clin. 62, 10-29
21. Bö ckelman, C., Koskensalo, S., Hagström, J., Lundin, M., Ristimä ki, A., and Haglund, C. (2012) CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biol. Ther. 13, 289-295
22. Satomaa, T., Heiskanen, A., Mikkola, M., Olsson, C., Blomqvist, M., Tiittanen, M., Jaatinen, T., Aitio, O., Olonen, A., Helin, J., Hiltunen, J., Natunen, J., Tuuri, T., Otonkoski, T., Saarinen, J., and Laine, J. (2009) The N-glycome of human embryonic stem cells. BMC Cell Biol. 10, 42
23. van Remoortere, A., Bank, C. M. C., Nyame, A. K., Cummings, R. D., Deelder, A. M., and van Die, I. (2003) Schistosoma mansoni-infected mice produce antibodies that cross-react with plant, insect, and mammalian glycoproteins and recognize the truncated biantennaryN-glycan Man3GlcNAc2-R. Glycobiology 13, 217-225
24. Robbe, C., Capon, C., Coddeville, B., and Michalski, J.-C. (2004) Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem. J. 384, 307-316
25. Saldova, R., Royle, L., Radcliffe, C. M., Hamid, U. M. A., Evans, R., Arnold, J. N., Banks, R. E., Hutson, R., Harvey, D. J., Antrobus, R., Petrescu, S. M., Dwek, R. A., and Rudd, P. M. (2007) Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17, 1344-1356
26. Bones, J., Byrne, J. C., O'Donoghue, N., McManus, C., Scaife, C., Boissin, H., Nastase, A., and Rudd, P. M. (2011) Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms. J. Proteome Res. 10, 1246-1265
27. Itzkowitz, S. H., Yuan, M., Fukushi, Y., Palekar, A., Phelps, P. C., Shamsuddin, A. M., Trump, B. F., Hakomori, S., and Kim, Y. S. (1986) Lewisx-and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonic tissues. Cancer Res. 46, 2627-2632
28. Hanski, C., Bornhoeft, G., Topf, N., Hermann, U., Stein, H., and Riecken, E. O. (1990) Detection of a mucin marker for the adenoma-carcinoma sequence inhuman colonic mucosa by monoclonal antibody AM-3. J. Clin. Pathol. 43, 379-384
29. Portela, S. V., Martín, C. V., Romay, L. M., Cuevas, E., Martín, E. G., and Briera, A. F. (2011) sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis. Histol. Histopathol. 26, 1305-1316
30. Cummins, J. M., He, Y. P., Leary, R. J., Pagliarini, R., Diaz, L. A., Sjoblom, T., Barad, O., Bentwich, Z., Szafranska, A. E., Labourier, E., Raymond, C. K., Roberts, B. S., Juhl, H., Kinzler, K. W., Vogelstein, B., and Velculescu, V. E. (2006) The colorectal microRNAome. Proc. Natl. Acad. Sci. U.S.A. 103, 3687-3692
31. van Engeland, M., Derks, S., Smits, K. M., Meijer, G. A., and Herman, J. G. (2011) Colorectal cancer epigenetics: complex simplicity. J. Clin. Oncol. 29, 1382-1391
32. Sharma, S., Kelly, T. K., and Jones, P. A. (2010) Epigenetics in cancer. Carcinogenesis 31, 27-36